Search for: "Abbvie, Inc."
Results 21 - 40
of 143
Sort by Relevance
|
Sort by Date
1 Nov 2021, 8:09 am
AbbVie Inc., et al., No. 14-5151 (E.D. [read post]
28 Oct 2021, 7:40 am
While it was Judge Maltese’s court-commissioned report on APKS that grabbed media attention in recent weeks, the New York trial continues against remaining defendants Allergan Finance (a subsidiary of AbbVie Inc.), Teva Pharmaceutical Industries Ltd. and Anda, Inc. [read post]
28 Oct 2021, 7:40 am
While it was Judge Maltese’s court-commissioned report on APKS that grabbed media attention in recent weeks, the New York trial continues against remaining defendants Allergan Finance (a subsidiary of AbbVie Inc.), Teva Pharmaceutical Industries Ltd. and Anda, Inc. [read post]
20 Sep 2021, 1:23 am
§ 271(e)(2)(C). [2] AbbVie Inc. v. [read post]
20 Sep 2021, 1:23 am
§ 271(e)(2)(C). [2] AbbVie Inc. v. [read post]
16 Sep 2021, 12:57 pm
” The New York State trial is expected to continue into October with remaining defendants Allergan Finance (a subsidiary of AbbVie Inc.), Teva Pharmaceutical Industries Ltd. and Anda, Inc. [read post]
16 Aug 2021, 6:32 am
” Furthermore, drugmakers AbbVie, Teva, and Endo are also missing from the settlement even though they “have been accused of misleadingly marketing their pain medicines as safe. [read post]
30 Jul 2021, 7:01 am
The New York State opioid trial continues against three major drugmakers, Endo International Plc., Teva Pharmaceutical Industries Ltd., and AbbVie Inc’s Allergan unit, which all stand accused of having deceptively marketed their opioid painkillers. [read post]
16 Jul 2021, 12:53 pm
” AbbVie Deutschland GmbH & Co. v. [read post]
3 Jun 2021, 4:15 am
The Board issued another five or so Fintiv denials, including one over an International Trade Commission (ITC) date, and only a handful of merits denials; it includes one, listed below, where the Board found merit to some minority of the challenged grounds but nonetheless denied after SAS Institute, Inc. v. [read post]
19 Apr 2021, 8:01 am
“Opioid Judge Withdraws After AbbVie Elevates His Atty Sister” — “Despite drugmaker warnings of “harmful and unwarranted” disruption, an Illinois magistrate judge withdrew Thursday from Chicago’s bellwether case against drugmakers in multidistrict opioid litigation after the city flagged his sister’s new role overseeing thousands of opioid cases for AbbVie Inc. [read post]
15 Apr 2021, 1:42 pm
In August, the FDA declined to approve Gilead Inc’s experimental rheumatoid arthritis treatment filgotinib, which also belongs to the same class of oral drugs. [read post]
15 Apr 2021, 10:51 am
Antitrust: Abbvie Inc v. [read post]
9 Apr 2021, 10:01 am
AbbVie Inc. v. [read post]
8 Mar 2021, 7:00 am
AbbVie, Inc.4. [read post]
16 Feb 2021, 7:57 pm
” AbbVie (Fed. [read post]
21 Oct 2020, 11:03 am
AbbVie Inc., the U.S. [read post]
12 Oct 2020, 9:59 pm
AbbVie Inc. [read post]
7 Oct 2020, 9:00 am
AbbVie, Inc. [read post]
1 Oct 2020, 10:46 am
AbbVie, Inc., joining the Seventh Circuit in holding that the FTC is not entitled to seek disgorgement under Section 13(b) of the FTC Act. [read post]
